Patents Act 1970: The Ultimate Guide for 2027

Every inventor in India eventually meets one statute. That statute is the Patents Act 1970. It decides what you can patent, how you apply, who can challenge you, and how you enforce your rights, so every filer needs it. This guide explains the Patents Act 1970 in plain words. You will also see the latest court rulings and the 2024 rule changes that affect filings today.

What Is the Patents Act 1970?

The Patents Act 1970 is India’s central law on patents. Parliament passed it as Act No. 39 of 1970. Its stated purpose is “to amend and consolidate the law relating to patents.” In short, it grants an inventor a time-bound monopoly. In return, the inventor must disclose the invention fully to the public.

Territorially, the law extends across India. The Ministry of Commerce and Industry administers it. Meanwhile, the Controller General of Patents, Designs and Trade Marks supervises the Indian Patent Office. Branch offices operate in Kolkata, Mumbai, Delhi and Chennai.

Quick Facts About the Indian Patent Act 1970

• Enacted: 19 September 1970 (Act 39 of 1970)
• Replaced: the Indian Patents and Designs Act 1911
• Patent term: 20 years from the filing date
• Subordinate law: the Patents Rules 2003, as amended in 2024
• Appeals: High Courts, since the Tribunals Reforms Act 2021 removed the IPAB

History: Why India Replaced the 1911 Law

Before 1970, India followed the colonial Patents and Designs Act 1911. That law mainly served foreign patent holders. Rules under the Patents Act 1970 later reversed that tilt. Consequently, local industry struggled to make affordable medicines and chemicals. Foreign firms held most Indian patents, yet few of them manufactured anything locally, so local industry gained little.

After independence, the government acted. An expert body known as the Ayyangar Committee studied the system closely. Its report urged a new approach. Accordingly, Parliament passed the Patents Act 1970 and ended the old scheme. Since then, the Patents Act 1970 has guided every Indian patent grant.

Process Patents Only: The Original Design

Boldly, the original statute allowed only process patents for food, drugs, and chemicals. Product patents in those fields, in other words, were barred. As a result, Indian firms could reverse-engineer a medicine by using a different process. Indeed, generic manufacturing flourished. India soon earned the title “pharmacy of the developing world.”

Furthermore, the original term was short for these fields. Inventors received five to seven years only. Tight design reflected a clear philosophy. Patents should reward invention without choking public access.

Key Amendments to the Indian Patent Act 1970

Global trade rules then forced change. India joined the World Trade Organization, and the TRIPS Agreement took effect in 1995. TRIPS sets minimum standards for patent protection in all member states. Three waves of amendments therefore followed.

The 1999, 2002 and 2005 Reforms

First came the 1999 amendment. It created the “mailbox” system and introduced exclusive marketing rights. Next, the 2002 amendment extended the term to twenty years and modernised procedures. Soon after, the Patents Rules 2003 followed.

Then arrived the biggest reform. The Patents (Amendment) Act 2005 introduced product patents for drugs, food and chemicals. At the same time, Parliament inserted Section 3(d). Blocking “evergreening,” a tactic of patenting minor tweaks to known medicines, is its aim.

Later Changes

The abolition of the Intellectual Property Appellate Board came with the Tribunals Reforms Act 2021. Appeals now reach the High Courts. Additionally, the Jan Vishwas (Amendment of Provisions) Act 2023 refreshed several provisions across central laws. Readers should therefore consult an updated Patent Act 1970 bare act before relying on any section number.

Structure of the Patents Act 1970 at a Glance

The statute runs to 160-plus sections across chapters. Knowing the map helps you find answers fast, because each chapter has a clear role. Below, a table shows the main blocks.

Moreover, a schedule at the end amends the older 1911 law. Online copies of the Patent Act 1970 bare act appear on the India Code portal, the Indian Patent Office website, and several law libraries.

Patents Act 1970 bare act: Key Definitions Under Section 2

Section 2 of the Patent Act 1970 bare act sets the vocabulary. Three definitions matter most because every application depends on them. First, an “invention” means a new product or process that involves an inventive step and is capable of industrial application. Second, an “inventive step” is a feature that makes the invention non-obvious to a skilled person. Third, “capable of industrial application” means someone can make or use the invention in an industry.

Courts read these definitions together, since each limb supports the others. Thus, an idea that fails any one limb cannot earn a patent. Likewise, “patentee” covers the person recorded as grantee or owner of the patent.

Novelty and Prior Art

Novelty, however, does not appear as a stand-alone definition. Instead, the law tests it through prior publication, prior claiming, and public knowledge. For example, prior existence of a similar idea anywhere in the world defeats the application. Inventors should therefore search prior art before they file.

What Can You Patent in India?

Any process or product can earn protection if it passes the three core tests of the Patents Act 1970. It must be new, it must involve an inventive step, and it must have industrial use. Besides, the specification must describe it clearly enough for a skilled reader to repeat it.

Real examples show the range. For instance, mechanical devices, chemical compounds, electronic circuits, manufacturing methods and pharmaceutical formulations all qualify. Software-linked inventions can qualify too, but only with a technical effect. We discuss that point shortly, because it trips many applicants.

Sufficiency of Disclosure

Section 10 of the Patent Act 1970 bare act demands a full description. Claims must define the scope, and the best method of working the invention must also appear. Notably, Section 10(4) ties protection to what the claims actually cover. Vague drafting consequently invites refusal or later revocation.

Inventions Not Patentable Under Sections 3 and 4

Chapter II of the Patents Act 1970 lists subject matter that falls outside the law. Section 3 says what is “not an invention.” Atomic energy inventions face a separate bar in Section 4. Together, they form the main filter for patent applications in India.

Section 3(d): The Evergreening Filter

Section 3(d) of the Indian Patent Act 1970 bars the “mere discovery” of a new form of a known substance. To qualify, the new form must show enhanced efficacy. Salts, polymorphs, isomers, and similar derivatives count as the same substance unless they differ significantly in efficacy. Debate over this clause continues today.

Section 3(k): Software and Business Methods

Computer programmes “per se,” mathematical or business methods and algorithms fall outside patent law under Section 3(k). Nevertheless, the Patent Office accepts inventions with a real technical contribution. Guidelines from 2017 on computer-related inventions explain the approach. Many applicants still face objections, so careful drafting is vital.

Other Common Exclusions

More exclusions deserve a quick look:

• Section 3(b): inventions whose commercial use would harm public order or morality
• Section 3(c): discovery of a scientific principle or of substances found in nature
• Section 3(h): methods of agriculture or horticulture
• Section 3(i): methods of medical treatment, whether surgical or therapeutic
• Section 3(j): plants, animals and essentially biological processes
• Section 3(p): traditional knowledge, or an aggregation of known properties of traditionally known components

Novartis v. Union of India: The Landmark Test of Section 3(d)

On 1 April 2013, the Supreme Court decided this case. Novartis had sought a patent on the beta-crystalline form of imatinib mesylate, sold as Glivec. The Patent Office refused the application, and the dispute travelled through the Madras High Court and the IPAB. Eventually, it reached the Supreme Court.

Dismissal then followed. The Justices held that the new form failed the efficacy test under Section 3(d). In its view, “efficacy” in the pharmaceutical context means therapeutic efficacy. Moreover, the Court found no proof of significantly better therapeutic results.

Earlier, in 2007, the Madras High Court had rejected Novartis’s challenge to the constitutional validity of Section 3(d). Novartis did not appeal that ruling, even though it lost. Thus, the clause stands firmly today within the Patents Act 1970.

Why the Ruling Still Matters

Every drug-related filing now feels this decision. Applicants must also prove real clinical benefit for a modified compound. In 2026, a Delhi High Court ruling in Syngenta Participations AG v. Controller of Patents and Designs clarified that non-pharmaceutical products need not show “therapeutic efficacy” under the same clause.

Who Can File a Patent Application in India?

Section 6 of the Patents Act 1970 lists eligible applicants. The Indian Patent Act 1970 treats an assignee like the inventor for this purpose. A true and first inventor may apply. So may an assignee of that inventor. Similarly, the legal representative of a deceased person may file. Importantly, a first importer of an invention does not count as the true inventor.

Applications can be made alone or jointly under the Indian Patent Act 1970. Companies and individuals both qualify, but each must hold the right to apply. Startups, small entities and educational institutions enjoy reduced official fees, which lowers the entry barrier.

Foreign Filing Licence for Residents

Indian residents face a special duty under Section 39. They must not file abroad first without written permission from the Controller. Alternatively, they may file in India first and wait six weeks before filing overseas. Secrecy directions for sensitive inventions can come from the government under Section 35. Violations still attract penalties and may even lead to refusal.

Step-by-Step Patent Filing Process in India

The path from idea to grant follows a clear sequence under the Patents Act 1970. Below, each step maps to the relevant provision.

Step 1: Search and Draft

First, run a prior art search. Next, draft a specification with claims. A provisional filing helps if the invention is still maturing.

Step 2: File the Application

File with the right Patent Office, using the prescribed forms. Correct office selection depends on the applicant’s address or the invention’s origin. Online filing is now the norm today.

Step 3: Publication

Under Section 11A, the Patent Office publishes the application eighteen months from the priority date. However, early publication is available on request. Publication also unlocks third-party opposition rights.

Step 4: Request for Examination

Section 11B of the Patent Act 1970 requires a request for examination. After the 2024 rule change, the time limit stands at 31 months from the priority date or filing date, whichever is earlier. Startups, small entities, and certain other categories can seek expedited examination.

Step 5: Examination and Grant

Examiners issue a First Examination Report. The applicant then has six months, extendable by three, to put the application in order. Finally, the Controller grants the patent under Section 43, and the Patent Office publishes it in the Journal.

Provisional vs. Complete Specification

Provisional specifications are allowed under Section 9. Early priority at lower cost is the main benefit, so many applicants start here. Within twelve months, a complete specification must follow. Missing this deadline therefore abandons the application.

Why the Priority Date Matters

Novelty cut-off is fixed by the priority date. Therefore, any later disclosure by others cannot defeat your claim. Priority from a foreign filing can be claimed within twelve months, thanks to Section 135 and the Paris Convention.

PCT National Phase

India belongs to the Patent Cooperation Treaty. Entry into the Indian national phase is possible within 31 months of the priority date. Thus, a single international application can open the Indian market without a fresh start.

Duty to Disclose Foreign Filings

Reporting corresponding foreign applications is mandatory under Section 8. Relief arrives in the 2024 rules, which ease this burden. Accessible databases can now supply much of that information to the Controller. Nonetheless, wrong or missing statements can still cause refusal or revocation.

Pre-Grant and Post-Grant Opposition

The Patents Act 1970 offers two opposition windows. Both strengthen the system by filtering weak patents, which also saves court time.

Pre-Grant Opposition Under Section 25(1)

Any person may file a representation after publication and before grant. Grounds include wrongful obtaining, prior publication, prior claiming, public knowledge, obviousness, lack of patentability under Sections 3 and 4, insufficient disclosure, and non-disclosure of foreign filings. Also, the Controller reviews the representation for a prima facie case. Tighter procedures and shorter related timelines came with the 2024 rules.

Post-Grant Opposition Under Section 25(2)

Within one year of publication of the grant, a “person interested” may oppose. From there, an Opposition Board examines the matter. Then the Controller decides after hearing both sides.

Hearing Rights

Procedural fairness remains a live issue. In Fresenius Kabi Ipsum v. Assistant Controller of Patents and Designs, the Delhi High Court held that an applicant still deserves a hearing under Section 14. Such a right survives even after a pre-grant opposition hearing under Section 25(1). Hence, the two processes remain separate.

Grant, Term and Renewal of Patents

As Section 53 of the Indian Patent Act 1970 provides, the patent term is twenty years from the filing date. Renewal fees fall due every year, starting when the third year begins. Missed payments therefore cause a patent to lapse. Restoration is possible within the prescribed period, though.

Improvements on a main patent get protection through a patent of addition. Its term then matches the main patent. Surrender is likewise possible when an owner no longer wants protection.

Working Statements: Form 27

Information about how the patent is worked in India can be sought by the Controller under Section 146. Previously, patentees filed Form 27 yearly. Filing now happens once every three financial years under the 2024 rules. Compliance pressure falls considerably as a result.

Rights of a Patentee Under Section 48

Section 48 of the Patents Act 1970 spells out the exclusive rights. Owners of a product patent can stop others from making, using, offering for sale, selling, or importing the product without consent. For a process patent, the owner can block use of the process by others. Use, sale, or import of the product made directly by that process also falls within the owner’s control.

Limits still apply to these rights. Coverage extends only to what the claims say, so drafting matters. Furthermore, protection runs within India alone. Foreign patents carry no effect here, and Indian patents carry none abroad. Rights under the Patent Act 1970 therefore need separate filings in each country.

Ownership, Assignment and Licensing

Patent rights are also transferable property. Assignments must be in writing and registered with the Patent Office, so that the register stays accurate. Thereafter, the assignee steps into the owner’s shoes. Co-owners hold equal undivided shares, yet one co-owner cannot grant a licence or assign a share without the others’ consent.

Licences also need written agreements. Registration also protects the licensee against later claims. Clear contracts reduce disputes down the road. Well-drafted terms also state royalties, territory, and duration.

Compulsory Licensing: Public Interest Over Monopoly

The Patents Act 1970 balances private rights with public needs. Chapter XVI then sets the compulsory licence scheme. Under Section 84 of the Patents Act 1970, any interested person can apply within three years of the grant. Applicants must show one of three grounds. The public’s reasonable requirements may be unmet, the invention may be unavailable at a reasonably affordable price, or the invention may not be worked in India.

Natco v. Bayer: India’s First Compulsory Licence

India’s first compulsory licence came on 9 March 2012. Natco Pharma sought to sell a generic version of Bayer’s kidney and liver cancer drug, sorafenib tosylate. Bayer sold it under the brand Nexavar, while Natco wanted a cheaper version. Voluntary licence talks with Bayer failed first.

All three grounds were, in fact, found proven. Royalty was then fixed at 6 percent of Natco’s net sales. Free supply of the drug to 600 needy patients each year was also required of Natco. Subsequently, the IPAB upheld the order in March 2013. Later, the Bombay High Court dismissed Bayer’s challenge on 15 July 2014.

Emergency and Export Provisions

National emergencies, extreme urgency and public non-commercial use justify compulsory licences under Section 92. Separately, Section 92A allows export of patented medicines to countries with insufficient manufacturing capacity. Inspiration for this provision came from the Doha Declaration on TRIPS and Public Health.

Government Use and Acquisition of Inventions

The Patents Act 1970 protects national interest in other ways too. Government use for its own purposes applies to every patent, as Section 47 states. Sections 99 to 102 expand on this. Public-purpose use of an invention is open to the Central Government, and it can even acquire a patent after paying fair compensation.

In practice, these powers are rare. Still, they act as a backstop. They remind patentees that the monopoly serves society as well.

Patent Infringement, Remedies and Defences

Infringement of a patent under the Patents Act 1970 occurs when someone performs a protected act without the owner’s permission. Suits go before a District Court or a High Court with original jurisdiction under Section 104. Once a counterclaim for revocation arrives, the case moves to the High Court.

Reliefs Under Section 108

Injunctions, damages, or an account of profits are all available from courts. Interim injunctions often decide the real outcome. Parties therefore fight hard at that stage. Early in 2026, a Delhi High Court ruling held that when validity is challenged, the court must make a more rigorous prima facie assessment before granting interim relief.

Defences Open to Defendants

Defendants may plead any ground of revocation under Section 107. Two special defences come from Section 107A. First, acts done solely for research, experiment or instruction are protected. Second, importation of patented products from a person lawfully authorised to produce and sell them is allowed. Parallel imports and exhaustion arguments rely on that second defence.

Innocent Infringement and Groundless Threats

Damages against innocent infringers face limits under Section 111. Likewise, groundless threats of infringement suits draw a remedy under Section 106. Patentees must thus verify before they send aggressive notices.

Revocation and Appeals

Section 64 of the Patents Act 1970 lists the grounds for revocation. Petitions to a High Court can come from any interested person. Defendants in a suit can also counterclaim. Typical grounds include lack of novelty, obviousness, non-patentable subject matter, insufficient description, wrongful obtaining and suppression of foreign filing details.

Revocation in the public interest can also be sought by the Central Government, and a patentee may surrender a patent voluntarily. Since the Tribunals Reforms Act 2021, Section 117A routes appeals from the Controller’s orders to the High Court. As such, High Courts now shape Indian patent jurisprudence under the Indian Patent Act 1970 directly.

Patents Rules 2003 and the 2024 Amendments

The Patents Act 1970 works with the Patents Rules 2003. Forms, fees and deadlines all sit in those rules. On 15 March 2024, the Patents (Amendment) Rules 2024 came into force. One day later, a Second Amendment followed.

Key Procedural Changes

Everyday practice feels these changes:

• Examination request: the deadline now stands at 31 months.
• Form 27: filing is due once every three financial years.
• Foreign applications: the Controller can use accessible databases for Section 8 information.
• Grace period: a twelve-month window covers disclosures at certain notified exhibitions and learned-society presentations.
• Pre-grant opposition: the procedure for early refusal and hearings is tighter.
• Extension requests: Form 4 now handles delay and extension requests.
• Patent agents: the qualifying exam also tests the Designs Act and Rules.

Overall, the reforms aim to cut delay and compliance costs. Review of docketing systems against the new timelines is therefore wise.

Latest Judgments and Trends in 2026

Courts keep refining the Patents Act 1970. Several decisions from 2026 deserve attention.

Mental Acts and Software Inventions

On 4 August 2026, Justice Tushar Rao Gedela of the Delhi High Court heard T-Mobile’s appeal against a 2016 refusal. He noted that the Patent Office lacked guidelines on “mental act” objections. The Court appointed an amicus to help frame a standard approach. Software applicants can thus expect clearer examination rules soon.

Standard Essential Patents and Exhaustion

Philips v. Rajesh Bansal drew wide attention. Overturning the earlier decree, a Division Bench of the Delhi High Court found no proof of essentiality or infringement. Exhaustion under Section 107A(b) also featured in its findings. Philips then moved the Supreme Court, which agreed to hear the appeal on 8 July 2026 and ordered status quo. Separately, another bench reinforced that FRAND duties run both ways in a dispute between Malikie and Xiaomi.

Procedure and Deadlines

Timelines have drawn judicial focus as well. A separate ruling refused to let an applicant use Section 57 amendments to revive an application after the statutory deadline had passed. Conversely, the court has protected applicants where the Controller raised new objections without notice. Procedural fairness and strict compliance therefore sit side by side.

Why the Patents Act 1970 Matters to Startups and Researchers

Young companies live on ideas. A granted patent turns an idea into an asset. Investors read patents as proof of technical depth. Acquirers value them during due diligence. Banks sometimes accept them as part of a funding story.

Universities and labs also gain. Publicly funded researchers can license patents to industry. Such licences bring revenue and real-world impact. Meanwhile, the Patents Act 1970 keeps the public domain alive. Expired patents pass freely to everyone. Each generation then builds on the last.

Public health supplies another lens. Compulsory licensing, opposition rights, and Section 3(d) all aim at affordable medicine. Critics argue these tools discourage investment. Supporters counter that they protect patients. Both views shape policy debates, and neither disappears soon.

Practical Tips for Inventors and Startups

Smart planning under the Patents Act 1970 saves money and rights. Follow these practical points:

• File early. An early filing date secures priority.
• Keep it confidential. Public disclosure before filing can destroy novelty, apart from narrow grace exceptions.
• Draft with Section 3 in mind. Frame software inventions around technical effect and drug inventions around proven efficacy.
• Track deadlines. Missing the examination request or reply deadline can end your application.
• Use startup benefits. Reduced fees and expedited examination help young companies.
• Hire a registered patent agent. Professional drafting reduces objections.
• Monitor competitors. Public databases show new filings in your field.
• Plan licensing early. Clear terms help partners trust your patent portfolio.

Common Mistakes to Avoid

Narrow claims trip up many applicants. Others forget to record assignments. Disclosures under Section 8 get overlooked often. Refusal or revocation then follows. Careful review before each filing prevents these costly errors. Peer review by a second attorney catches drafting gaps early. Likewise, a short checklist of dates, forms, and fees keeps the file clean. Both habits cost little and save a great deal. Strong records also help during later disputes, licensing talks, and investor reviews.

How the Patents Act 1970 Differs From Other IP Laws

Patents protect inventions. Other laws protect other creations. The visual shape of articles falls under the Designs Act 2000. Original expression such as code, text and music belongs to the Copyright Act 1957. Brand identifiers receive cover through the Trade Marks Act 1999. By contrast, trade secrets rely on contracts and equity.

Many businesses use several of these tools together with the Patents Act 1970. For example, a smartphone maker may patent a circuit, register a design for the case, and trademark its logo. Accordingly, a layered strategy gives the strongest shield.

Conclusion: Using the Patents Act 1970 Wisely

The Patents Act 1970 remains the backbone of Indian innovation law. It rewards invention, yet it protects public access. Amendments, court rulings, and the 2024 rules keep it responsive to modern needs.

For inventors, the message is simple. Understand what the law protects, file early, and manage deadlines. Businesses gain both a shield and a set of limits from the same statute. Consult a qualified patent attorney for advice on your own invention. Finally, always verify section numbers against the latest official Patent Act 1970 bare act text.

References

1. Indian Patent Office, “Patents Rules” page: https://ipindia.gov.in/Patents/rules_patents
2. Gazette copy of the Patents (Amendment) Rules, 2024: https://www.ipindia.gov.in/writereaddata/Portal/IPORule/1_83_1_Patent_Amendment_Rule_2024_Gazette_Copy.pdf
3. The Patents Rules, 2003 (Indian Patent Office): https://ipindia.gov.in/writereaddata/Portal/IPORule/1_6_1_patent-rules-2003.pdf
4. Text of the Patents Act, 1970 (hosted by the Japan Patent Office): https://www.jpo.go.jp/e/system/laws/gaikoku/document/index/india-e_patents_act.pdf
5. Section 48, Patents Act, 1970 (AdvocateKhoj): https://www.advocatekhoj.com/library/bareacts/patents/48.php
6. Section 45, Patents Act, 1970 (AdvocateKhoj): https://www.advocatekhoj.com/library/bareacts/patents/45.php
7. Amendment footnotes to the Patents Act, 1970 (AdvocateKhoj): https://www.advocatekhoj.com/library/bareacts/patents/footnotes.php
8. Section 162 and repeal of the 1911 Act (AdvocateKhoj): https://www.advocatekhoj.com/library/bareacts/patents/162.php
9. UNCTAD IP Case Law, Novartis AG v. Union of India (2013): https://unctad.org/ippcaselaw/novartis-ag-v-union-india-others-supreme-court-india-1-april-2013
10. Nishith Desai Associates, Novartis Supreme Court judgment analysis: https://nishithdesai.com/research-and-articles/hotline/ip-hotline/novartis-indian-supreme-court-judgment-what-is-efficacy-for-pharmaceutical-invention-5824
11. Bombay High Court judgment, Bayer Corporation v. Union of India (2014): https://future.indiankanoon.org/doc/28519340/
12. SpicyIP, India’s first compulsory licence order: https://spicyip.com/2012/03/breaking-news-indias-first-compulsory.html
13. WTO, Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS): https://www.wto.org/english/docs_e/legal_e/27-trips.pdf
14. WIPO, Patent Cooperation Treaty (PCT): https://www.wipo.int/pct/en/
15. LexOrbis via Mondaq, India announces changes in Patents Rules, 2003: https://www.mondaq.com/india/patent/1440942/india-announces-progressive-changes-in-patents-rules-2003
16. Anand and Anand, India patent courts come of age (2026): https://www.anandandanand.com/news-insights/india-patent-courts-come-of-age-amid-key-rulings-and-stronger-enforcement/
17. IAM, Fresenius Kabi Ipsum v. Assistant Controller of Patents and Designs: https://www.iam-media.com/article/delhi-high-court-clarifies-pre-grant-opposition-does-not-replace-examination-hearing
18. LiveLaw Business, Delhi High Court guidelines on “mental acts” (2026): https://www.livelawbiz.com/amp/patent/delhi-high-court-frames-guidelines-to-distinguish-mental-acts-from-patentable-inventions-544506
19. Maheshwari & Co., Delhi High Court on SEP patent exhaustion (2026): https://www.maheshwariandco.com/press-release/delhi-hc-sep-patent-exhaustion-ruling-2026/
20. Legal 500, Delhi High Court on priority-date amendments: https://www.legal500.com/intelligence/india/intellectual-property/patent-deadlines-cannot-be-rewritten-delhi-high-court-clarifies-the-limits-of-priority-date-amendments